Jun 17, 2020
Rigel to Present at the BMO 2020 Prescriptions for Success Healthcare Virtual Conference
May 05, 2020
Rigel Reports First Quarter 2020 Financial Results and Provides Business Update
Apr 27, 2020
Rigel Announces Conference Call and Webcast to Report First Quarter 2020 Financial Results and Business Update
Feb 27, 2020
Rigel Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Business Update
Feb 20, 2020
Rigel Announces Conference Call and Webcast to Report Fourth Quarter and Year End Financial Results
Jan 09, 2020
Rigel to Present at the 38th Annual J.P. Morgan Healthcare Conference
Dec 17, 2019
Rigel Announces Chief Commercial Officer Transition
Nov 15, 2019
Rigel Receives Positive CHMP Opinion for Fostamatinib Disodium Hexahydrate for Adult Patients with Chronic Immune Thrombocytopenia (ITP) in Europe
Nov 13, 2019
Rigel to Present at Jefferies 2019 London Healthcare Conference
Oct 29, 2019
Rigel Announces Conference Call and Webcast to Report Third Quarter 2019 Financial Results
Oct 16, 2019
Rigel to Host Investor and Analyst Call on October 23, 2019
Oct 02, 2019
Rigel Secures Credit Facility for Up to $60 Million
Aug 28, 2019
Rigel's CEO to Participate in Panel Discussion at Citi's 14th Annual Biotech Conference
Aug 06, 2019
Rigel Announces Second Quarter 2019 Financial Results and Provides Business Update
May 31, 2019
Rigel to Present at Jefferies 2019 Healthcare Conference
Apr 30, 2019
Rigel Announces Conference Call and Webcast to Report First Quarter 2019 Financial Results and Company Update
Mar 26, 2019
Rigel Welcomes Jane Wasman to Board of Directors
Feb 28, 2019
Rigel Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Company Update
Jan 23, 2019
Rigel Pharmaceuticals Enters Collaboration and License Agreement with Grifols, S.A. to Commercialize Fostamatinib in Europe
Dec 05, 2018
Rigel to Present at the BMO Capital Markets 2018 Prescriptions for Success Healthcare Conference in New York City